BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32240265)

  • 21. Brain-enriched microRNAs circulating in plasma as novel biomarkers for Rett syndrome.
    Sheinerman K; Djukic A; Tsivinsky VG; Umansky SR
    PLoS One; 2019; 14(7):e0218623. PubMed ID: 31291284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of circulating microRNAs as markers in detecting and predicting congenital heart defects in children.
    Song Y; Higgins H; Guo J; Harrison K; Schultz EN; Hales BJ; Moses EK; Goldblatt J; Pachter N; Zhang G
    J Transl Med; 2018 Feb; 16(1):42. PubMed ID: 29482591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of microRNA expression in plasma and skeletal muscle of thoroughbred racehorses in training.
    McGivney BA; Griffin ME; Gough KF; McGivney CL; Browne JA; Hill EW; Katz LM
    BMC Vet Res; 2017 Nov; 13(1):347. PubMed ID: 29166903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome.
    Kwee LC; Neely ML; Grass E; Gregory SG; Roe MT; Ohman EM; Fox KAA; White HD; Armstrong PW; Bowsman LM; Haas JV; Duffin KL; Chan MY; Shah SH
    Physiol Genomics; 2019 Oct; 51(10):506-515. PubMed ID: 31530226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
    Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
    Front Immunol; 2018; 9():3099. PubMed ID: 30687316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of circulating microRNA: preanalytical and analytical challenges.
    McDonald JS; Milosevic D; Reddi HV; Grebe SK; Algeciras-Schimnich A
    Clin Chem; 2011 Jun; 57(6):833-40. PubMed ID: 21487102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preanalytical considerations for clinical assays of circulating human miRNA-451a, miRNA-423-5p and miRNA-199a-3p for diagnostic purposes.
    Chandel DS; Tom WA; Jiang C; Krzyzanowski G; Fernando N; Olou A; Fernando MR
    PLoS One; 2024; 19(5):e0303598. PubMed ID: 38768135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating miRNA signatures of early pregnancy in cattle.
    Ioannidis J; Donadeu FX
    BMC Genomics; 2016 Mar; 17():184. PubMed ID: 26939708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Biobanked Serum from a Mycobacterium avium subsp paratuberculosis Bovine Infection Model Confirms the Remarkable Stability of Circulating miRNA Profiles and Defines a Bovine Serum miRNA Repertoire.
    Shaughnessy RG; Farrell D; Riepema K; Bakker D; Gordon SV
    PLoS One; 2015; 10(12):e0145089. PubMed ID: 26675426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges and standardization of microRNA profiling in serum and cerebrospinal fluid in dogs suffering from non-infectious inflammatory CNS disease.
    Cirera S; Andersen-Ranberg EU; Langkilde S; Aaquist M; Gredal H
    Acta Vet Scand; 2019 Dec; 61(1):57. PubMed ID: 31796072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
    Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
    Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total circulating cell-free miRNA in plasma as a predictive biomarker of the thyroid diseases.
    Caglar O; Cayir A
    J Cell Biochem; 2019 Jun; 120(6):9016-9022. PubMed ID: 30506793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating miRNA Signature as a Potential Biomarker for the Prediction of Analgesic Efficacy of Hydromorphone.
    Kiyosawa N; Watanabe K; Toyama K; Ishizuka H
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Several circulating miRNAs related to hyperlipidemia and atherosclerotic cardiovascular diseases.
    Xu J; Chen Z; Wang Y; Wang X; Chen L; Yuan T; Tang X; Lu Y; Chen H; Chen M; Duan Z; Fan J; Liang J; Zhang X
    Lipids Health Dis; 2019 Apr; 18(1):104. PubMed ID: 31010436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating microRNAs as potential diagnostic biomarkers for osteoporosis.
    Mandourah AY; Ranganath L; Barraclough R; Vinjamuri S; Hof RV; Hamill S; Czanner G; Dera AA; Wang D; Barraclough DL
    Sci Rep; 2018 May; 8(1):8421. PubMed ID: 29849050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.
    Momen-Heravi F; Saha B; Kodys K; Catalano D; Satishchandran A; Szabo G
    J Transl Med; 2015 Aug; 13():261. PubMed ID: 26264599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sources to variability in circulating human miRNA signatures.
    Keller A; Rounge T; Backes C; Ludwig N; Gislefoss R; Leidinger P; Langseth H; Meese E
    RNA Biol; 2017 Dec; 14(12):1791-1798. PubMed ID: 28820329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability in microRNA recovery from plasma: Comparison of five commercial kits.
    Brunet-Vega A; Pericay C; Quílez ME; Ramírez-Lázaro MJ; Calvet X; Lario S
    Anal Biochem; 2015 Nov; 488():28-35. PubMed ID: 26271186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating microRNAs as potential biomarkers for the identification of vascular dementia due to cerebral small vessel disease.
    Prabhakar P; Chandra SR; Christopher R
    Age Ageing; 2017 Sep; 46(5):861-864. PubMed ID: 28633305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating miRNAs as biomarkers for severe acute pancreatitis associated with acute lung injury.
    Lu XG; Kang X; Zhan LB; Kang LM; Fan ZW; Bai LZ
    World J Gastroenterol; 2017 Nov; 23(41):7440-7449. PubMed ID: 29151698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.